184 abstracts found.



The incidence of non-ovarian cancers in women with elevated CA125 levels in General Practice

Year:

Session type:

Theme:

Garth Funston1,Willie Hamilton2,Gary Abel2,Emma Crosbie3,Brian Rous4,Fiona Walter5

1Department of Public Health and Primary Care, University of Cambridge,2University of Exeter,3Gynaecological Oncology Research Group, Division of Cancer Sciences, University of Manchester,4National Cancer Registration and Analysis Service, Public Health England,5Department of Public Health and Primary Care, University of Cambridge, Cambridge

The predictive value of CA125 for ovarian cancer in General Practice: a population-based cohort study of over 50,000 women

Year:

Session type:

Theme:

Garth Funston1,Willie Hamilton2,Gary Abel2,Emma Crosbie3,Brian Rous4,Fiona Walter1

1Department of Public Health and Primary Care, University of Cambridge,2University of Exeter,3Gynaecological Oncology Research Group, Division of Cancer Sciences, University of Manchester,4National Cancer Registration and Analysis Service, Public Health England

Interim results from the IMPACT study: evidence for PSA screening in BRCA2 mutation carriers

Year:

Session type:

Theme:

Rosalind Eeles1,Elizabeth Page2,Elizabeth Bancroft3,Mark Brook1,Melissa Assel4,Judith Offman5,Zsofia Kote-Jarai1,Andrew Vickers4,Hans Lilja4,The IMPACT study Steering Committee and IMPACT study collaborators6

1The Institute of Cancer Research, London, UK,2The Institute of Cancer Research,3Royal Marsden NHS Foundation Trust, London, UK,4Memorial Sloan Kettering Cancer Center, New York, US,5King’s College London, London, UK,6the Institute of Cancer Research

Non-invasive methylation test to detect cervical pre-cancer in self-collected vaginal and urine specimens

Year:

Session type:

Theme:

Belinda Nedjai1,Caroline Reuter1,Toni Hollingworth1,Janet Austin1,Louise Cadman1,Jack Cuzick1,Attila Lorincz1

1Queen Mary University of London, London, UK

Prospective clinical validation of novel serum biomarker test for the identification of patients at risk of brain tumour.

Year:

Session type:

Theme:

Paul Brennan1,Holly Butler2,Mark Hegarty3,Ben Smith2,David Palmer2,Michael Jenkinson4,Matt Baker5

1university of edinburgh,2University of Strathclyde,3Clin Spex Dx Ltd,4University of Liverpool,5university of Strathclyde

Occupational exposure and smoking adjusted risk of bladder cancer. Population based cohort studies in the Nordic countries.

Year:

Session type:

Theme:

Kishor Hadkhale1,Jan Ivar Martinsen2,Elisabete Weiderpass3,Kristina Kjaerheim2,Par Sparen4,Laufey Tryggvadottir5,Elsebeth Lynge6,Eero Pukkala7,Tom K Grimsrud2
1Tampere University, Tampere, Finland,2Cancer registry of Norway, Oslo, Norway,3International Agency for Research on Cancer, Lyon, France,4Karolinska Institute, Stockholm, Sweden,5Icelandic cancer registry, Reykjavik, Iceland,6University of Copenhagen, Copenhagen, Denmark,7Finnish cancer registry, Helsinki, Finland

Is gynaecological cancer stage affected by pre-referral pelvic examination: a linked data study?

Year:

Session type:

Theme:

Pauline Williams1,Peter Murchie1,Maggie Cruickshank1,Christine Bond1,Chris Burton2,Dolapo Ayansina1
1University of Aberdeen,2University of Sheffield

Methylation Sensitive High Resolution Melting (MS-HRM) Assay for the Detection of BRCA1 and BRCA2 Promoter Hypermethylation

Year:

Session type:

Theme:

Diana Pelka1,Jack Grant1,Sasha Hansel1,David Moore1,Phil Bennett1,Geraldine Thomas2,Gareth Gerrard1
1Sarah Cannon Molecular Diagnostics, London, UK,2Imperial College London, London, UK

Acceptability of circulating microRNAs for testicular germ cell malignancy: validation of an initial user consultation exercise

Year:

Session type:

Theme:

Lorna Fern1,Michelle Greenwood2,Sue Brand3,Dan Stark4,Mathew Murray5
1University College London Hospitals,2St Bartholomew's Hospital London,3It’s in the Bag,4University of Leeds,5Cambridge University Hospitals

A novel capillary nano-immunoassay towards rapid, quantitative measurement of cell cycle biomarkers in clinical trials

Year:

Session type:

Theme:

Eleanor Tiplady1,Krishna Yalla1,Eilidh McCulloch1,Alan Bilsland1,Kathrin Heinzmann2,Fiona Thomson1
1University of Glasgow,2Cancer Research UK

Circulating Ensembles of Tumor Associated Cells are Ubiquitous in Breast, Ovarian and Cervical Cancers and Atypical in Asymptomatic Individuals.

Year:

Session type:

Theme:

Dadasaheb Akolkar1,Darshana Patil1,Raymond Page2,Vineet Datta1,Revati Patil1,Pradip Fulmali1,Pooja Fulmali1,Navin Srivastava1,Pradip Devhare1,Sachin Apurwa1,Shoeb Patel1,Sanket Patil1,Ajay Srinivasan1,Rajan Datar1
1Datar Cancer Genetics Limited,2Worcester Polytechnic Institute

Renal cell carcinoma patients under 60 should be screened for colorectal carcinoma

Year:

Session type:

Theme:

Joseph John1,Eleanor Burden2,Edward Smyth1,Adam Chambers1
1Taunton and Somerset NHS Foundation Trust, Taunton, UK,2Royal Devon and Exeter Hospital, Exeter, UK

Making Big Data available: Informatics Infrastructure supporting the MRC/CRUK funded Stratification in COloRecTal Cancer (S-CORT) programme

Year:

Session type:

Theme:

Andrew Blake1,Enric Domingo1,Michael Youdell1,Susan Richman2,Peter Stewart3,Celina Whalley4,Clare Hardy5,Katerina Chatazipli5,on behalf of S-CORT Consortium6,Tim Maughan1
1University of Oxford,2University of Leeds,3Queens University Belfast,4University of Birmingham,5Wellcome Trust Sanger Institute,6S-CORT Consortium

Explaining socio-economic differences in bladder cancer survival

Year:

Session type:

Theme:

Beth Russell1,Mieke Van Hemelrijck1,Truls Gårdmark2,Lars Holmberg1,Pardeep Kumar3,Andrea Bellavia4,Christel Häggström5
1King's College London, London, UK,2Karolinska Institute, Stockholm, Sweden,3Royal Marsden NHS Foundation Trust, London, UK,4Havard T.H Chan School of Public Health, Boston, US,5Uppsala University, Uppsala, Sweden

A multiplex proteomics analysis reveals a novel plasma biomarker signature that predicts for outcomes in gastro-oesophageal cancer

Year:

Session type:

Theme:

Eilidh McCulloch1,Alan Bilsland1,Liz-Anne Lewsley2,Antonia MacMillan2,Martin MacLeod2,Jennifer Walker1,Jamie Stobo2,James Paul2,W. Nicol Keith1,Patricia Roxburgh1,Fiona Thomson1,T.R. Jeffry Evans1
1Glasgow ECMC, Institute of Cancer Science, University of Glasgow,2CRUK Clinical Trials Unit, Institute of Cancer Science, University of Glasgow

Co-expression of Transglutaminase 2 and TP53 and breast cancer prognosis

Year:

Session type:

Theme:

Fiona Blows1,Fiona Blows1,Peter Coussons2,Claire Pike2,Paul Pharoah3
1Anglia Ruskin University and University of Cambridge,2Anglia Ruskin University,3University of Cambridge

Development and validation of a risk prediction model for lung cancer with common health examination indexes

Year:

Session type:

Theme:

Zhangyan Lyu1,Ni Li1,Fengwei Tan1,Jiang Li1,Chunqing Lin1,Hongda Chen1,Jiansong Ren1,Jufang Shi1,Kai Su1,Fang Li1,Xiaoshuang Feng1,Luopei Wei1,Xin Li1,Yan Wen1,Gang Wang2,Shuohua Chen2,Shouling Wu2,Min Dai1,Jie He1
1National Cancer Center, Beijing, China, National Clinical Research Center for Cancer, Beijing, China, Cancer Hospital, Beijing, China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,2Kailuan General Hospital, Tangshan, China

Is pelvic examination a key part of a patient’s gynaecological cancer diagnostic journey? A qualitative study of GPs and specialists.

Year:

Session type:

Theme:

Pauline Williams1,Maggie Cruickshank1,Christine Bond1,Christ Burton2,Peter Murchie1
1University of Aberdeen,2University of Sheffield

Verification of a Cartridge-based Microsatellite Instability (MSI) Platform and Cross-platform Assessment of Cases with Rare Germline Polymorphic Markers

Year:

Session type:

Theme:

Gareth Gerrard1,Diana Pelka2,Nicole Gurunlian1,Georgina Briggs1,Jack Grant1,Kevin Balibi1,Phil Bennett1
1Sarah Cannon Molecular Diagnostics,2HCA Healthcare UK

Clinical validation of serum Raman spectroscopy as a primary care triage test for colorectal cancer.

Year:

Session type:

Theme:

Susan Chandler1,Cerys Jenkins2,Rhys Jenkins2,Dean Harris1,Peter Dunstan2
1Swansea Bay University Health Board,2Swansea University

An Analysis of Prognostic Biomarkers of the Systemic Inflammatory Response in Cancers of Unknown Primary

Year:

Session type:

Theme:

Rebekah Patton1,Rebekah Patton1,Gillian Knowles1,Rachel Haigh1,Lucy Dobbs2,Barry Laird1,Colin Barrie1,Sally Clive1
1NHS Lothian, Edinburgh, UK,2University of Edinburgh, Edinburgh, UK

Characterising novel patient tumour tissue-derived organoid models for in vitro research

Year:

Session type:

Theme:

Ibrahim Khot1,Roberto Coppo2,Masahiro Inoue2,David Jayne1
1University of Leeds,2Kyoto University

NORAD2: an enhancer RNA that strongly activates DCBLD2 gene transcription upon drug treatment

Year:

Session type:

Theme:

Andrei Zheltukhin1,Dmitry Karpov1,Pavel Spirin1,Olga Zinovieva1,Evgenia Grineva1,George Krasnov1,Tamara Mashkova1,Nikolai Lisitsyn1
1Engelhardt Institute of Molecular Biology

Formation of occupational cancer risk groups in order to optimize malignant tumors early detection on the example of workers employed in metallurgical shops with different methods of copper production

Year:

Session type:

Theme:

Marie Fallon1,Vadim Adrianovskiy1,Yelena Kuz'mina1,Georgiy Lipatov1
1Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers

Assessment of tissue composition with digital pathology in colorectal cancer

Year:

Session type:

Theme:

Enric Domingo1,Aikaterini Chatzipli2,Susan Richman3,Andrew Blake1,Claire Hardy2,Celina Whalley4,Keara Redmond5,Ian Tomlinson4,Philip Dunne5,Steven Walker6,Andrew Beggs4,Ultan McDermott2,Graeme Murray7,Leslie Samuel8,Matt Seymour3,Philip Quirke3,Tim Maughan1,Viktor Koelzer9
1University of Oxford, Oxford, UK,2Wellcome Trust Sanger Institute, Cambridge, UK,3Leeds Institute of Cancer and Pathology, Leeds, UK,4University of Birmingham, Birmingham, UK,5Queen's University Belfast, Belfast, UK,6Almac Diagnostics, Craigavon, UK,7University of Aberdeen, Aberdeen, UK,8Aberdeen Royal Infirmary, Aberdeen, UK,9University of Zurich, Zurich, Switzerland

Radical (chemo)radiotherapy in a population-based dataset of real-world patients with oropharyngeal cancer: comparison of 7th and 8th staging systems

Year:

Session type:

Theme:

Francesca De Felice1,Thomas Bird2,Andriana Michaelidou3,Selvam Thavaraj4,Edward Oddell4,Ann Sandison4,Gillian Hall4,Peter Morgan4,Andrew Lyons4,Luke Cascarini4,Alastair Fry4,Richard Oakley4,Ricard Simo4,Jean Pierre Jeannon4,Miguel Reis Ferreira4,Mary Lei4,Teresa Guerrero Urbano4
1Guy's and St Thomas' NHS Foundation Trust, London, Sapienza University of Rome, Rome, Italy,2Bristol Cancer Institute, Horfield Road, Bristol, BS2 8ED,3King's College London and Kent Oncology Centre,4Guy's and St Thomas' NHS Foundation Trust

A high-throughput sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia

Year:

Session type:

Theme:

Eleanor Watt1
1UCL

Detection of EGFR mutations in the plasma and urine of NSCLC EGFRm+ patients

Year:

Session type:

Theme:

Ling Li1,Sebastian Oltean1,Helen Brooks2,Charles Comins2,Alfredo Addeo2,Megan Stevens1
1University of Exeter,2University Hospitals Bristol NHS Foundation Trust

Survival outcomes in oropharyngeal cancer: a decision tree analysis

Year:

Session type:

Theme:

Francesca De Felice1,Laia Humbert-Vidan2,Mary Lei2,Andrew King2,Teresa Guerrero Urbano2
1Guy's and St Thomas' NHS Foundation Trust, London, Sapienza University of Rome, Rome, Italy,2Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Quantitative secretomics analysis of stem and non-stem cells of two different stages of colon cancer cell lines

Year:

Session type:

Theme:

Jeyalakshmi Kandhavelu1,Kumar Subramanian1,Previn Naicker2,Stoyan Stochev2,Paul Ruff1,Clement Penny1
1University of the Witwatersrand,2Council for Scientific and Industrial Research

Accelerating early identification of cancer in primary care using an artificial intelligent driven solution.

Year:

Session type:

Theme:

Bhavagaya Bakshi1
1C the Signs

Could novel inhibition of acid ceramidase with LCL521 have a translatable role for locally advanced rectal cancer?

Year:

Session type:

Theme:

Rachael Clifford1,Naren Govindarajah1,David Bowden1,Paul Sutton1,Aiping Bai2,Zdzislaw Szulc2,Besim Ogretmen2,Jason Parsons1,Dale Vimalachandran3
1Institute of Cancer Medicine, The University of Liverpool,2Medical University of South Carolina,3The Countess of Chester Hospital

Lung cancer survival in seven high-income countries 2010-2014: assessing the impact of stage at diagnosis by sex (the ICBP SURVMARK-2 project)

Year:

Session type:

Theme:

Marzieh Araghi1,Miranda Fidler-Benaoudia2,Melina Arnold3,Eileen Morgan3,Mark Rutherford4,Freddie Bray3,Isabelle Soerjomataram3
1University College London,2Cancer Control Alberta,3International Agency for Research on Cancer (IARC/WHO),4University of Leicester

A biobank analysis of outcomes in patients with malignancy of undefined primary origin

Year:

Session type:

Theme:

Mark Stares1,Rebekah Patton1,Gillian Knowles1,Rachel Haigh1,Colin Barrie1,Lucy Dobbs2,Barry Laird2,Sally Clive1
1NHS Lothian,2Edinburgh University

Assessment of systemic metabolic biomarkers to predict prostate cancer progression and mortality

Year:

Session type:

Theme:

Meda R Sandu1,Diana L. Santos Ferreira1,Rebecca Richmond1,Lucy Hackshaw-McGeagh1,Eleanor Walsh1,Michael Davis1,Emma Turner1,Freddie C. Hamdy1,The ProtecT study group2,J Athene Lane1,Richard M Martin1
1University of Bristol,2multiple

3-D cell culture models for detection of biomarker indicating anti-EGFR antibody resistance in colon cancer patients

Year:

Session type:

Theme:

Jens Hahne1,Andrea Lampis1,Michele Ghidini2,Margherita Ratti2,Massimiliano Salati1,Chiara Senti2,Rodolfo Passalacqua2,Luciano Cascione3,Chiara Braconi1,Owen Sansom4,Matteo Fassan5,Nicola Valeri1
1The Institute of Cancer Research London,2Istituti Ospitalieri di Cremona,3Institute of Cancer Research Belinzola,4The Beatson Institute for Cancer Research,5University of Padua

Interferon-related signalling dictates prognosis in the fibroblast-rich subtype of stage II and III colon cancer

Year:

Session type:

Theme:

Amy McCorry1,Rene Jackstadt2,Dustin Flanagan2,S:cort Consortium3,ACRCelerate Consortium4,Owen Sansom2,Mark Lawler1,Philip Dunne1
1Queen's University Belfast,2Cancer Research UK Beatson Institute,3S:CORT Consortium,4ACRCelerate

Improving Outcomes For Immunotherapy-Induced Endocrinopathies in Metastatic Melanoma

Year:

Session type:

Theme:

Christina Peters1,Carolyn Tang1,Joyce Ntata1,Yvette Moore1,Ankit Rao1,Poulam Patel1
1Nottingham University Hospitals NHS Trust

SWATH mass spectrometry: Quantitative mapping of soft tissue sarcomas by digital proteome profiling

Year:

Session type:

Theme:

Lukas Krasny1,Martina Milighetti1,Alexander T.J. Lee1,Aik-Choon Tan2,Robin Jones3,Paul H. Huang1
1The Institute of Cancer Research, London, UK,2University of Colorado, Aurora, US,3Royal Marsden Hospital, London, UK

Engineered 3D-microtumours for personalized cancer therapy

Year:

Session type:

Theme:

Nobina Mukherjee1,Prof. Hagan Bayley1
1University of Oxford

Mutation analysis of Beta2-Microglobulin identifies a subset of deficient mismatch repair (dMMR) colorectal cancers which are protected from disease recurrence.

Year:

Session type:

Theme:

Susan Richman1,Paul Barrow2,Andrew Wallace3,Kelly Handley4,Gordon Hutchins5,David Kerr6,Laura Magill4,Gareth Evans3,Richard Gray6,Phil Quirke5,James Hill2
1Leeds Teaching Hospitals NHS Trust,2Manchester Royal Infirmary,3Central Manchester University Hospitals NHS Trust,4University of Birmingham,5University of Leeds,6University of Oxford

Guideline discordant diagnostic care: when do primary care referrals not reflect guidelines for suspected cancer?

Year:

Session type:

Theme:

Bianca Wiering1,Georgios Lyratzopoulos2,Willie Hamilton1,John Campbell1,Gary Abel1
1University of Exeter,2UCL

Accurate targeted long-read DNA methylation sequencing with TAPS.

Year:

Session type:

Theme:

Yibin Liu1,Yibin Liu1,Jingfei Cheng1,Paulina Siejka-Zielinska1,Chunxiao Song1
1University of Oxford

Non-Attendance in Two-week wait and Urgent Colorectal Cancer Referrals

Year:

Session type:

Theme:

Vincenza Scanella1,Harpreet Sekhon Inderjit Singh2,Rabiya Aseem2,Jason Smith2,Nikhil Pawa2
1Imperial College London, London, UK,2West Middlesex University Hospital, Isleworth, UK

Discovery of prognostic biomarkers from the prostate cancer membrane proteome using bioorthogonal chemistry.

Year:

Session type:

Theme:

Lynn Asante-Asare1,Mike Deery2,Renata Feret2,Yagnesh Umrania2,Jodi Miller1,Cara Brodie1,Jo Arnold1,André Neves1,Kevin Brindle1
1Cancer Research UK Cambridge Institute,2Cambridge Centre for Proteomics

Expression of non-coding RNAs in early stage breast cancer and their prognostic implications

Year:

Session type:

Theme:

Krishna Patel1,Arunagiri Kuha Deva Magendhra Rao2,Shirley Sundersingh2,Veluswami Sridevi2,Thangarajan Rajkumar2,Bipin Nair3,Akhilesh Pandey4,Aditi Chatterjee1,Samson Mani2,Harsha Gowda1
1Institute of Bioinformatics,2Cancer Institute (WIA),3Amrita Vishwa Vidyapeetham,4Mayo Clinic

High plasmatic IL-8 and low nitrites levels are independent predictors of poor prognosis in nasopharyngeal carcinoma patients

Year:

Session type:

Theme:

Ahmed Amine Zergoun1,Taha Merghoub2,Chafia Touil-Boukoffa3,Mehdi Bourouba3
1University of M'hamed Bougara, Boumerdes,2MSKCC,3USTHB

Clinical Utility of Autoantibodies in Early Detection of Breast Cancer

Year:

Session type:

Theme:

Daniyah Alfattani1
1CEAC group

CT Scan to Screen for Occult Cancer in Unprovoked Venous Thromboembolism (VTE)

Year:

Session type:

Theme:

CHUN WAI Wong1,Kelly Lim1,Rachel Garnett1,Harris Khan1,Faisal Solkar1,Shahab Abbas1
1ROYAL STOKE UNIVERSITY HOSPITAL

Concurrent and Future risk of Endometrial Cancer in women with Endometrial Hyperplasia: A systematic review and meta-analyses.

Year:

Session type:

Theme:

Úna McMenamin1,Michelle Doherty2,Omolara Sanni2,Helen Coleman2,Chris Cardwell2,Glenn McCluggage3,Declan Quinn4,James Wylie4
1Queen's University Belfast, Belfast, UK,2Queen's University Belfast,3Belfast Health and Social Care Trust,4Northern Health and Social Care Trust